Virginia Catalyst Announces Round 11 of Grant Funding – LOI due June 30
The Virginia Catalyst, formerly known as the Virginia Biosciences Health Research Corporation (VBHRC), announced that it is accepting letters of intent (LOI) for Grant Round 11 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advancing Virginia’s economy.
While all life science projects will be accepted for Grant Round 11, given the impact of COVID-19, emphasis will be placed on projects within the areas of infectious disease, immunology, vaccine and drug discovery, and innovative service delivery models including telehealth and telemedicine. Virginia Catalyst awards, which range from $200,000 to $800,000, help fund collaborative efforts between industry and Virginia research universities with goals of:
• Funding innovative, collaborative, translational research projects that elevate the level of sponsored research at Virginia’s universities and have the potential to create high value jobs in the Commonwealth
• Accelerating commercialization of Virginia research university inventions and discoveries and to achieve competitive critical mass through robust collaborations across Virginia
The LOI submission form, along with funding criteria and frequently asked questions, are available on the Virginia Catalyst website (www.virginiacatalyst.org/apply.html).
LOIs must be received by June 30, 2020 at 5:00 PM EDT. Projects that meet criteria will be invited to submit a full application by August 18, 2020. Awards will be announced in October 2020.